Cancer Biology

1198 Fragmentation patterns of cell-free DNA from urine differ between healthy individuals and those with cancer.

1197 Nonsurgical treatment of skin cancer with local delivery of bioadhesive nanoparticles.

1196 Percutaneous liquid ablation agent for tumor treatment and drug delivery.

1195 Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling.

1194 Resistance to immunotherapy can be overcome using fecal microbiota transplantation for patients with metastatic melanoma.

1193 Expression of the Epstein–Barr virus protein LMP1 in B cells increases expression of—and promotes T cell responses to—tumour-associated antigens, delineating a mechanism of infection-induced anti-tumour immunity, which could inform immune-based approaches to cancer treatment.

1192 Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy.

1191 Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin.

1190 ACE2 is protective against renal cancer, and its down-modulation by inhibitors of VEGF receptor signaling may mediate resistance to such inhibitors.

1189 Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer.

1188 Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity.

1187 Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer.

1186 The dose threshold for nanoparticle tumour delivery.

1185 Mesenchymal Stem Cells Functionalized Sonodynamic Treatment for Improving Therapeutic Efficacy and Compliance of Orthotopic Oral Cancer.

1184 Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma.

1183 Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division.

1182 Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy.

1181 Systemic cancer therapy with engineered adenovirus that evades innate immunity.

1180 CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.

1179 Fighting against Drug‐Resistant Tumors using a Dual‐Responsive Pt(IV)/Ru(II) Bimetallic Polymer.

Free Images for Presentation: sunipix SUNIPIX